ALDR on NASDAQ

Lundbeck Seattle Biopharmaceuticals

Logo: Lundbeck Seattle Biopharmaceuticals, Public domain, via Wikimedia Commons³

Pharmaceutical development company

Lundbeck Seattle Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Formerly known as Alder Biopharmaceuticals, it specializes in therapeutic monoclonal antibodies.² Its shares trade on NASDAQ under the symbol ALDR.¹ Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

Jan 1, 2004Founded¹

Compare with another stock.

TickerALDR on NASDAQ¹
Industrypharmaceutical industry¹
HeadquartersBothell¹
Websitewww.alderbio.com

See how the biggest companies compare on our leaderboards

Corporate structure

Lundbeck Seattle Biopharmaceuticals is part of a group headed by Lundbeckfond Invest. 9 entities, 5 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Lundbeckfond Invest Copenhagen, Denmark
- Falck Copenhagen, Denmark
  - Falck Helseformidling AS Subsidiary · Oslo, Norway
  - FALCK DANMARK A/S Subsidiary · 100% · København SV, Denmark
- Lundbeck Valby, Denmark
  - Lundbeck Seattle Biopharmaceuticals Bothell
  - Lundbeck (United States) Subsidiary · Deerfield, United States
  - Lundbeck España S.A. Subsidiary · Barcelona, Spain
  - Lundbeck Latvia, SIA Subsidiary · Latvia

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.

Subsidiaries and ownership

Parent company

Lundbeck

From Wikidata.¹

Timeline

Jan 1, 2004Founded Founded¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataLundbeck Seattle Biopharmaceuticals on Wikidata
2
WikipediaLundbeck Seattle Biopharmaceuticals on Wikipedia
3
Wikimedia CommonsLundbeck Seattle Biopharmaceuticals logo by Lundbeck Seattle Biopharmaceuticals, Public domain